Diabetes and arterial hypertension: what calcium antagonist to choose?
Gómez Huelgas, R.
Anales de Medicina Interna 14(11): 594-595
1997
ISSN/ISBN: 0212-7199 PMID: 9445591 Document Number: 482410
Document emailed within 1 workday
Related Documents
Zapesochnaia, I.L.; Avtandilov, A.G. 2014: The influence of combined therapy with calcium antagonist and angiotensin-converting enzyme inhibitor on the circadian profile of arterial pressure in patients with arterial hypertension in the Far North Klinicheskaia Meditsina 92(10): 33-40Forette, F.; Bellet, M.; Henry, J.F.; Hervy, M.P.; Poyard-Salmeron, C.; Bouchacourt, P. 1984: Treatment of arterial hypertension in the aged with a calcium antagonist: nicardipine Archives des Maladies du Coeur et des Vaisseaux 77(11): 1242-1246
Hergueta García de Guadiana, G.; Paumard Fraguas, A. 1989: Effects of a calcium antagonist, verapamil, on mild-moderate essential arterial hypertension Anales de Medicina Interna 6(1): 15-18
Runikhina, N.K.; Tkacheva, O.N. 2008: Efficacy of long acting calcium antagonist felodipine in smoking women with essential arterial hypertension Kardiologiia 48(9): 50-52
Shmidt, I.; Khomut, V.; Monike, V.; Bakh, K.; Fliugel', K. 1985: Central and peripheral hemodynamics during combined treatment of arterial hypertension with calcium antagonist nifedipine and beta-adrenergic blockader talinolol Kardiologiia 25(6): 110-111
Mick, D.G.; Broniarczyk, S.M.; Haidt, J. 2004: Choose, Choose, Choose, Choose, Choose, Choose, Choose: Emerging and Prospective Research on the Deleterious Effects of Living in Consumer Hyperchoice Journal of Business Ethics 52(2): 207-211
Mick, D.G.; Broniarczyk, S.M.; Haidt, J. 2004: Choose, Choose, Choose, Choose, Choose, Choose, Choose: Emerging and Prospective Research on the Deleterious Effects of Living in Consumer Hyperchoice Journal of Business Ethics 52(2): 207-211
Mick, D.G.; Broniarczyk, S.M.; Haidt, J. 2004: Choose, Choose, Choose, Choose, Choose, Choose, Choose: Emerging and Prospective Research on the Deleterious Effects of Living in Consumer Hyperchoice Journal of Business Ethics 52(2): 207-211
Mick, D.G.; Broniarczyk, S.M.; Haidt, J. 2004: Choose, Choose, Choose, Choose, Choose, Choose, Choose: Emerging and Prospective Research on the Deleterious Effects of Living in Consumer Hyperchoice Journal of Business Ethics 52(2): 207-211
Mick, D.G.; Broniarczyk, S.M.; Haidt, J. 2004: Choose, Choose, Choose, Choose, Choose, Choose, Choose: Emerging and Prospective Research on the Deleterious Effects of Living in Consumer Hyperchoice Journal of Business Ethics 52(2): 207-211
Mick, D.G.; Broniarczyk, S.M.; Haidt, J. 2004: Choose, Choose, Choose, Choose, Choose, Choose, Choose: Emerging and Prospective Research on the Deleterious Effects of Living in Consumer Hyperchoice Journal of Business Ethics 52(2): 207-211
Mick, D.G.; Broniarczyk, S.M.; Haidt, J. 2004: Choose, Choose, Choose, Choose, Choose, Choose, Choose: Emerging and Prospective Research on the Deleterious Effects of Living in Consumer Hyperchoice Journal of Business Ethics 52(2): 207-211
Mick, D.G.; Broniarczyk, S.M.; Haidt, J. 2004: Choose, Choose, Choose, Choose, Choose, Choose, Choose: Emerging and Prospective Research on the Deleterious Effects of Living in Consumer Hyperchoice Journal of Business Ethics 52(2): 207-211
Mick, D.G.; Broniarczyk, S.M.; Haidt, J. 2004: Choose, Choose, Choose, Choose, Choose, Choose, Choose: Emerging and Prospective Research on the Deleterious Effects of Living in Consumer Hyperchoice Journal of Business Ethics 52(2): 207-211
Mick, D.G.; Broniarczyk, S.M.; Haidt, J. 2004: Choose, Choose, Choose, Choose, Choose, Choose, Choose: Emerging and Prospective Research on the Deleterious Effects of Living in Consumer Hyperchoice Journal of Business Ethics 52(2): 207-211
Nicita-Mauro, V.; Barbera, N.; Savica, V.; Frisina, N.; Ceruso, D. 1978: Influence of calcium antagonist, nifedipine, on arterial pressure. Preliminary considerations Bollettino Della Societa Italiana di Cardiologia 23(2): 389-397
Goloshchapov, O.A.; Goldabin, V.I. 1990: Variants of hemodynamic reactions to the calcium antagonist finoptin in patients with hypertension Kardiologiia 30(12): 63-64
Matsumoto, J.; Minami, T.; Sato, T.; Onodera, T. 1992: A clinical trial of arterial infusion chemotherapy combined with calcium antagonist for liver metastases Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(10 Suppl): 1553-1556
Baliakina, E.V.; Atakhanov, S.E.; Gabbasov, Z.A.; Popov, E.G.; Iurenev, A.P. 1992: The effect of long-term therapy with a calcium antagonist on thrombocyte function in hypertension patients Terapevticheskii Arkhiv 64(8): 39-43
Escudero, J.; Hernandez, H. 1991: Clinical evaluation of amlodipine, a new long-acting calcium antagonist, in mild and moderate hypertension International Journal of Clinical Pharmacology Research 11(5): 243-246